Evidence map›Paper›PMID 38246410›Full record

ArticleJournal of molecular biology2024

Rapid Optogenetic Clustering in the Cytoplasm with BcLOVclust.

Zikang Huang Dennis, William Benman, Liang Dong, Lukasz J Bugaj

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
7.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Chemical reviews · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Protein design accelerates the development and application of optogenetic tools.Computational and structural biotechnology journal · 2025
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Zikang Huang DennisDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
William BenmanDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Liang DongDepartment of Biochemistry, University of Pennsylvania, Philadelphia, PA 19104, USA.
Lukasz J BugajDepartment of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104, USA; Institute of Regenerative Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: bugaj@seas.upenn.edu.
University of Pennsylvania · USCalifornia Institute for Regenerative Medicine · US

Funding

Harnessing protein clustering to understand, identify, and manipulate cellular systemsR35GM138211 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI Lukasz Bugaj · 2020 to 2026
$3.3M
Acquisition of a Cell Sorter for Systems Biology and Cellular EngineeringS10OD026986 · OD · UNIVERSITY OF PENNSYLVANIA · PI BUGAJ, LUKASZ · 2020 to 2020
$439k
NIGMS NIH HHS R35 GM138211NIH HHS S10 OD026986
6 · The paper itself

Abstract

Protein clustering is a powerful form of optogenetic control, yet remarkably few proteins are known to oligomerize with light. Recently, the photoreceptor BcLOV4 was found to form protein clusters in mammalian cells in response to blue light, although clustering coincided with its translocation to the plasma membrane, potentially constraining its application as an optogenetic clustering module. Herein we identify key amino acids that couple BcLOV4 clustering to membrane binding, allowing us to engineer a variant that clusters in the cytoplasm and does not associate with the membrane in response to blue light. This variant-called BcLOVclust-clustered over many cycles with substantially faster clustering and de-clustering kinetics compared to the widely used optogenetic clustering protein Cry2. The magnitude of clustering could be strengthened by appending an intrinsically disordered region from the fused in sarcoma (FUS) protein, or by selecting the appropriate fluorescent protein to which it was fused. Like wt BcLOV4, BcLOVclust activity was sensitive to temperature: light-induced clusters spontaneously dissolved at a rate that increased with temperature despite constant illumination. At low temperatures, BcLOVclust and Cry2 could be multiplexed in the same cells, allowing light control of independent protein condensates. BcLOVclust could also be applied to control signaling proteins and stress granules in mammalian cells. While its usage is currently best suited in cells and organisms that can be cultured below ∼30 °C, a deeper understanding of BcLOVclust thermal response will further enable its use at physiological mammalian temperatures.

Indexed as

Adaptor Proteins, Signal TransducingCryptochromesGolgi Matrix ProteinsOptogeneticsAnimalsCell MembraneCluster AnalysisCytoplasmLightProtein MultimerizationAdaptor Proteins, Signal TransducingCryptochromesGolgi Matrix ProteinsGOPC protein, humanBcLOV4Cry2G3BP1Optogeneticsphotoreceptorplasma membraneprotein clusteringRhoAtemperature sensitivity

Identifiers

PMID38246410
PMCPMC10932838
OpenAlexW4391069617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.